Literature DB >> 2664067

Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.

T Hoang1, B Levy, N Onetto, A Haman, J C Rodriguez-Cimadevilla.   

Abstract

TNF-alpha has been shown to antagonize the proliferative effects of growth factors present in crude conditioned media from PHA-stimulated leukocytes or cell lines on the clonogenic cells of acute myeloblastic leukemia (AML) (19,21). In the present study, we investigated the responses of AML blasts to TNF-alpha in the presence of defined growth factors (recombinant granulocyte/macrophage-CSF [rGM-CSF], recombinant granulocyte-CSF [rG-CSF], rIL-3, and rIL-1) and under conditions described for autocrine stimulation (32). While TNF-alpha antagonized the stimulatory effects of G-CSF and IL-3 on blast progenitors, TNF-alpha did not affect blast colony formation in the presence of IL-1. Unexpectedly, TNF-alpha significantly enhanced blast proliferation in the presence of GM-CSF. Further, TNF-alpha also acted synergistically with an endogenous source of growth stimulatory signal to promote proliferation of blast clonogenic cells. Thus, on human leukemic cells, TNF-alpha appears to be a molecule that is at least bifunctional, having the ability to either support or inhibit cell proliferation, depending on the other growth factors present. It is postulated that the proliferative response of blast progenitors to TNF-alpha under conditions that favor autocrine stimulation may represent one property that allows the cells to escape from negative regulation and proliferate in AML.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664067      PMCID: PMC2189388          DOI: 10.1084/jem.170.1.15

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Tumor necrosis factor: receptors on hematopoietic cells.

Authors:  R Munker; J DiPersio; H P Koeffler
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

2.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

Authors:  H E Broxmeyer; D E Williams; L Lu; S Cooper; S L Anderson; G S Beyer; R Hoffman; B Y Rubin
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

3.  Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

Authors:  T Murase; T Hotta; H Saito; R Ohno
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

4.  Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells.

Authors:  M Ohta; J S Greenberger; P Anklesaria; A Bassols; J Massagué
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

Authors:  D Y Mochizuki; J R Eisenman; P J Conlon; A D Larsen; R J Tushinski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.

Authors:  M A Moore; D J Warren
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

Authors:  J D Griffin; A Rambaldi; E Vellenga; D C Young; D Ostapovicz; S A Cannistra
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

8.  Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

Authors:  Y C Yang; A B Ciarletta; P A Temple; M P Chung; S Kovacic; J S Witek-Giannotti; A C Leary; R Kriz; R E Donahue; G G Wong
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

9.  Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia.

Authors:  T Hoang; N Nara; G Wong; S Clark; M D Minden; E A McCulloch
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

10.  Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia.

Authors:  C Kelleher; J Miyauchi; G Wong; S Clark; M D Minden; E A McCulloch
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

View more
  9 in total

1.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.

Authors:  I Plo; D Lautier; T Levade; H Sekouri; J P Jaffrézou; G Laurent; A Bettaïeb
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.

Authors:  Yuki Kagoya; Akihide Yoshimi; Keisuke Kataoka; Masahiro Nakagawa; Keiki Kumano; Shunya Arai; Hiroshi Kobayashi; Taku Saito; Yoichiro Iwakura; Mineo Kurokawa
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.

Authors:  O Elbaz; L M Budel; H Hoogerbrugge; I P Touw; R Delwel; L A Mahmoud; B Löwenberg
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1.

Authors:  M A Brach; H J Gruss; C Sott; F Herrmann
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia.

Authors:  Tian Yi Zhang; Ritika Dutta; Brooks Benard; Feifei Zhao; Raymond Yin; Ravindra Majeti
Journal:  Sci Transl Med       Date:  2020-04-08       Impact factor: 17.956

7.  High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.

Authors:  W Digel; F Porzsolt; M Schmid; F Herrmann; W Lesslauer; M Brockhaus
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia.

Authors:  Hakan Ozdogu; Can Boga; Zerrin Yilmaz; Feride Iffet Sahin; Nebil Bal
Journal:  Rheumatol Int       Date:  2006-12-20       Impact factor: 3.580

Review 9.  Regulation of hematopoietic and leukemic stem cells by the immune system.

Authors:  C Riether; C M Schürch; A F Ochsenbein
Journal:  Cell Death Differ       Date:  2014-07-04       Impact factor: 15.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.